Responses
Oral Presentations – Monday, September 26, 2005
0003 ADDING A QUADRIVALENT (6, 11, 16 & 18 TYPES) HUMAN PAPILLOMAVIRUS VACCINE TO THE EXISTING UK CERVICAL SCREENING PROGRAMME IS POTENTIALLY COST-EFFECTIVE
Compose a Response to This Article
Other responses
No responses have been published for this article.